Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 53

Sort by

Sort Order Select

Journal Articles

Microbiota modification in hematology: still at the bench or ready for the bedside?

Christopher J. Severyn, Ryan Brewster, Tessa M. Andermann

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 303–314.

https://doi.org/10.1182/hematology.2019000365

Published: 2019

Journal Articles

Optimizing cord blood selection

Annalisa Ruggeri

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 522–531.

https://doi.org/10.1182/hematology.2019000056

Published: 2019

Journal Articles

Biology-driven developments in the therapy of acute graft-versus-host disease

Robert Zeiser

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 236–241.

https://doi.org/10.1182/asheducation-2018.1.236

Published: 2018

Journal Articles

GVHD: biology matters

James L. M. Ferrara, Mohammed S. Chaudhry

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 221–227.

https://doi.org/10.1182/asheducation-2018.1.221

Published: 2018

Journal Articles

Alternative donor transplants for severe aplastic anemia

Andrea Bacigalupo

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 467–473.

https://doi.org/10.1182/asheducation-2018.1.467

Published: 2018

Journal Articles

Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation

Betty Ky Hamilton

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 228–235.

https://doi.org/10.1182/asheducation-2018.1.228

Published: 2018

Journal Articles

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Robert J. Soiffer, Yi-Bin Chen

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 699–707.

https://doi.org/10.1182/asheducation-2017.1.699

Published: 2017

Journal Articles

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Jennifer Schneiderman

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 639–644.

https://doi.org/10.1182/asheducation-2017.1.639

Published: 2017

Journal Articles

Graft versus tumor effects and why people relapse

J. H. Frederik Falkenburg, Inge Jedema

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 693–698.

https://doi.org/10.1182/asheducation-2017.1.693

Published: 2017

Journal Articles

Role of the intestinal mucosa in acute gastrointestinal GVHD

Jonathan U. Peled, Alan M. Hanash, Robert R. Jenq

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 119–127.

https://doi.org/10.1182/asheducation-2016.1.119

Published: 2016

Journal Articles

Transplantation for bone marrow failure: current issues

Régis Peffault de Latour

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 90–98.

https://doi.org/10.1182/asheducation-2016.1.90

Published: 2016

Journal Articles

Myelodysplastic and myeloproliferative disorders of childhood

Henrik Hasle

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 598–604.

https://doi.org/10.1182/asheducation-2016.1.598

Published: 2016

Journal Articles

Use of alternative donors for allogeneic stem cell transplantation

Claudio Anasetti

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 220–224.

https://doi.org/10.1182/asheducation-2015.1.220

Published: 2015

Journal Articles

Graft-versus-host disease versus graft-versus-leukemia

Robert S. Negrin

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 225–230.

https://doi.org/10.1182/asheducation-2015.1.225

Published: 2015

Journal Articles

New approaches to transplantation in acute myelogenous leukemia

Marcos de Lima

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 596–604.

https://doi.org/10.1182/asheducation-2015.1.596

Published: 2015

Journal Articles

Management of hemolytic anemia following allogeneic stem cell transplantation

Andreas Holbro, Jakob R. Passweg

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 378–384.

https://doi.org/10.1182/asheducation-2015.1.378

Published: 2015

Journal Articles

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

Sarah Nikiforow, Edwin P. Alyea

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 570–575.

https://doi.org/10.1182/asheducation-2014.1.570

Published: 2014

Journal Articles

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence

Koen van Besien

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 56–62.

https://doi.org/10.1182/asheducation-2013.1.56

Published: 2013

Journal Articles

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

Uwe Platzbecker

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 522–528.

https://doi.org/10.1182/asheducation-2013.1.522

Published: 2013

Journal Articles

Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL

Michael R. Verneris

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 335–341.

https://doi.org/10.1182/asheducation-2013.1.335

Published: 2013

NARROW

Microbiota modification in hematology: still at the bench or ready for the bedside?

Optimizing cord blood selection

Biology-driven developments in the therapy of acute graft-versus-host disease

GVHD: biology matters

Alternative donor transplants for severe aplastic anemia

Current approaches to prevent and treat GVHD after allogeneic stem cell transplantation

Pharmacologic agents to prevent and treat relapse after allogeneic hematopoietic cell transplantation

Extracorporeal photopheresis: cellular therapy for the treatment of acute and chronic graft-versus-host disease

Graft versus tumor effects and why people relapse

Role of the intestinal mucosa in acute gastrointestinal GVHD

Transplantation for bone marrow failure: current issues

Myelodysplastic and myeloproliferative disorders of childhood

Use of alternative donors for allogeneic stem cell transplantation

Graft-versus-host disease versus graft-versus-leukemia

New approaches to transplantation in acute myelogenous leukemia

Management of hemolytic anemia following allogeneic stem cell transplantation

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only